tiprankstipranks
TG Therapeutics (TGTX)
NASDAQ:TGTX
US Market
TGTX
TG Therapeutics
RESEARCH TOOLSreports
Want to see TGTX full AI Analyst Report?

TG Therapeutics (TGTX) Income Statement

2,124 Followers

TG Therapeutics Income Statement

Last quarter (Q4 2025), TG Therapeutics's total revenue was $192.57M, an increase of 78.00% from the same quarter last year. In Q4, TG Therapeutics's net income was $23.04M. See TG Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 616.29M$ 329.00M$ 233.66M$ 2.79M$ 6.69M
Gross Profit
$ 515.33M$ 290.52M$ 219.11M$ 2.52M$ 5.90M
Operating Expenses
$ 392.00M$ 248.59M$ 198.90M$ 220.84M$ 350.67M
Depreciation and Amortization
$ 244.00K$ 280.00K$ 423.00K$ 515.00K$ 494.00K
EBITDA
$ 134.36M$ 49.90M$ 26.10M$ -213.11M$ -341.97M
Operating Income
$ 123.32M$ 41.93M$ 20.63M$ -218.32M$ -344.77M
Other Income/Expenses
$ -15.93M$ -16.34M$ -7.57M$ -5.50M$ -3.33M
Pretax Income
$ 107.39M$ 25.59M$ 13.06M$ -223.81M$ -348.10M
Net Income
$ 447.18M$ 23.38M$ 12.67M$ -223.81M$ -348.10M
Per Share Metrics
Basic EPS
$ 3.10$ 0.16$ 0.09$ -1.46$ -2.63
Diluted EPS
$ 2.77$ 0.15$ 0.09$ -1.46$ -2.63
Weighted Average Shares Outstanding
 144.32M 145.32M 141.96M 135.41M 132.22M
Weighted Average Shares Outstanding (Diluted)
 161.41M 160.34M 148.51M 135.41M 132.22M
Currency in USD

TG Therapeutics Earnings and Revenue History